FDA warned Get.Fit.Medical that its website sold compounded sildenafil, tadalafil, semaglutide and tirzepatide with false 'generic' claims.
What happened
FDA reviewed https://www.getfitmedical.com in August 2025 and found it offered compounded (custom-mixed) sildenafil, tadalafil, semaglutide, and tirzepatide. The site described them as 'GENERIC VIAGRA,' 'GENERIC CIALIS,' 'GENERIC OZEMPIC/WEGOVY,' and 'GENERIC MOUNJARO.' FDA says those claims are false or misleading because compounded drugs are not FDA-approved, making the products misbranded (illegally labeled).
What FDA found
The website called compounded sildenafil 'generic Viagra,' implying it is the same as an FDA-approved drug when compounded sildenafil is not FDA-approved.
FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]The website called compounded tadalafil 'generic Cialis,' implying it is the same as an FDA-approved drug when compounded tadalafil is not FDA-approved.
FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]The website called compounded semaglutide 'generic Ozempic/Wegovy,' implying it is the same as FDA-approved drugs when compounded semaglutide is not FDA-approved.
FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]The website called compounded tirzepatide 'generic Mounjaro,' implying it is the same as an FDA-approved drug when compounded tirzepatide is not FDA-approved.
FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]FDA says introducing these illegally labeled drugs into interstate commerce is prohibited.
FDCA section 301(a) [21 U.S.C. § 331(a)]FDA says receiving or delivering these illegally labeled drugs is also prohibited.
FDCA section 301(c) [21 U.S.C. § 331(c)]
What FDA wants
FDA tells the company to take immediate action, including ceasing the misleading language, and to respond in writing within 15 working days with the steps taken, how it will prevent recurrence, and supporting documents.
Who should pay attention
- telehealth companies selling compounded drugs
- compounding pharmacies and outsourcing facilities
- advertising and marketing teams for drug websites
This is a summary. Read the original letter on fda.gov.